Pfm Health Sciences, LP: 13F holdings, Q2 2026
Hedge fund · SEC EDGAR filings (CIK 1442756) · Explore on the interactive board
Pfm Health Sciences, LP disclosed 96 US equity positions worth $1.2bn in its Q2 2026 13F filing (holdings as of June 30, 2026, filed August 14, 2026). Its largest position is ASND at 5.4% of the reported book, followed by AXSM, LLY. The top ten holdings are 34.3% of the book, and the portfolio behaves like about 50 equal-weight positions. Versus the prior filing it opened 33 new positions, added to 22, reduced 41 and exited 14. Note: this manager's most recent filing is 3934 quarters behind the newest quarter on file, so these figures are history rather than current positioning.
What does Pfm Health Sciences, LP own? Top holdings as of June 30, 2026
Change is measured in shares against the previous filing (Q1 2026), so price moves do not read as decisions. This quarter: 33 new, 22 added, 41 reduced, 14 exited.
| # | Stock | Sector | Weight | Value | Shares | Δ shares | Action |
|---|---|---|---|---|---|---|---|
| 1 | ASND ASCENDIS PHARMA A/S | Healthcare | 5.4% | $62.2m | 233,171 | – | new |
| 2 | AXSM AXSOME THERAPEUTICS INC. | Healthcare | 4.7% | $53.8m | 219,596 | -17% | reduced |
| 3 | LLY ELI LILLY & CO | Healthcare | 4.1% | $47.1m | 39,258 | -40% | reduced |
| 4 | JAZZ JAZZ PHARMACEUTICALS PLC | Healthcare | 3.4% | $38.7m | 160,768 | -10% | reduced |
| 5 | HUM HUMANA INC | Healthcare | 3.3% | $37.5m | 94,375 | – | new |
| 6 | UNH UNITEDHEALTH GROUP INC | Healthcare | 3.2% | $36.7m | 88,276 | 52% | added |
| 7 | NBIX NEUROCRINE BIOSCIENCES INC | Healthcare | 3.1% | $36.0m | 213,407 | -1% | reduced |
| 8 | INBX INHIBRX BIOSCIENCES INC | Healthcare | 2.5% | $29.2m | 308,385 | 1% | added |
| 9 | UTHR UNITED THERAPEUTICS CORP DEL | Healthcare | 2.4% | $27.1m | 49,991 | 26% | added |
| 10 | RVMD REVOLUTION MEDICINES INC | Healthcare | 2.3% | $26.8m | 143,222 | 2% | added |
| 11 | ICLR ICON PUB LTD CO | Healthcare | 2.1% | $23.7m | 136,482 | 137% | added |
| 12 | THC TENET HEALTHCARE CORP | Healthcare | 2.1% | $23.7m | 126,572 | -68% | reduced |
| 13 | EW EDWARDS LIFESCIENCES CORP | Healthcare | 2.0% | $22.7m | 250,453 | -2% | reduced |
| 14 | WAT WATERS CORP | Healthcare | 1.9% | $22.4m | 59,825 | 50% | added |
| 15 | PEN PENUMBRA INC | Healthcare | 1.7% | $19.0m | 60,221 | -57% | reduced |
| 16 | BBIO BRIDGEBIO PHARMA INC | Healthcare | 1.6% | $18.9m | 253,358 | -2% | reduced |
| 17 | SYK STRYKER CORPORATION | Healthcare | 1.5% | $17.8m | 56,637 | 158% | added |
| 18 | MTD METTLER TOLEDO INTERNATIONAL | Healthcare | 1.5% | $17.0m | 13,344 | – | new |
| 19 | INDV INDIVIOR PHARMACEUTICALS INC | Healthcare | 1.4% | $16.5m | 401,208 | -30% | reduced |
| 20 | MRK MERCK & CO INC | Healthcare | 1.4% | $16.3m | 127,118 | – | new |
| 21 | CYTK CYTOKINETICS INC | Healthcare | 1.4% | $16.3m | 191,686 | – | new |
| 22 | LNTH LANTHEUS HLDGS INC | Healthcare | 1.4% | $16.2m | 146,403 | – | new |
| 23 | CNC CENTENE CORP DEL | Healthcare | 1.4% | $16.0m | 248,867 | -6% | reduced |
| 24 | COO COOPER COS INC | Healthcare | 1.4% | $15.8m | 220,890 | 30% | added |
| 25 | MDGL MADRIGAL PHARMACEUTICALS INC | Healthcare | 1.4% | $15.7m | 29,313 | -14% | reduced |
| 26 | ACHC ACADIA HEALTHCARE COMPANY IN | Healthcare | 1.3% | $15.5m | 524,934 | -10% | reduced |
| 27 | ORKA ORUKA THERAPEUTICS INC | Healthcare | 1.3% | $15.1m | 158,825 | -9% | reduced |
| 28 | OSCR OSCAR HEALTH INC | Healthcare | 1.3% | $14.8m | 519,016 | 4% | added |
| 29 | TMO THERMO FISHER SCIENTIFIC INC | Healthcare | 1.2% | $14.3m | 28,496 | 92% | added |
| 30 | CVS CVS HEALTH CORP | Healthcare | 1.2% | $14.2m | 137,457 | – | new |
| 31 | MMSI MERIT MED SYS INC | Healthcare | 1.2% | $13.7m | 197,038 | 21% | added |
| 32 | PRAX PRAXIS PRECISION MEDICINES I | Healthcare | 1.1% | $12.9m | 38,575 | 9% | added |
| 33 | CLDX CELLDEX THERAPEUTICS INC NEW | Healthcare | 1.1% | $12.8m | 342,751 | 5% | added |
| 34 | NVO NOVO-NORDISK A S | Healthcare | 1.1% | $12.7m | 265,016 | 34% | added |
| 35 | ITGR INTEGER HLDGS CORP | Healthcare | 1.0% | $11.8m | 126,669 | -6% | reduced |
| 36 | DNTH DIANTHUS THERAPEUTICS INC | Healthcare | 1.0% | $11.8m | 121,222 | -30% | reduced |
| 37 | DFTX DEFINIUM THERAPEUTICS INC | Healthcare | 1.0% | $11.7m | 249,020 | 21% | added |
| 38 | GILD GILEAD SCIENCES INC | Healthcare | 1.0% | $11.5m | 90,858 | – | new |
| 39 | RYTM RHYTHM PHARMACEUTICALS INC | Healthcare | 1.0% | $11.3m | 101,550 | -26% | reduced |
| 40 | HSIC SCHEIN HENRY INC | Healthcare | 1.0% | $11.2m | 134,423 | -12% | reduced |
| 41 | ARWR ARROWHEAD PHARMACEUTICALS IN | Healthcare | 0.9% | $10.7m | 131,667 | 105% | added |
| 42 | TNGX TANGO THERAPEUTICS INC | Healthcare | 0.9% | $10.2m | 326,047 | -20% | reduced |
| 43 | TFX TELEFLEX INCORPORATED | Healthcare | 0.9% | $10.1m | 79,708 | – | new |
| 44 | VKTX VIKING THERAPEUTICS INC | Healthcare | 0.9% | $10.0m | 255,330 | -3% | reduced |
| 45 | BTSG BRIGHTSPRING HEALTH SVCS INC | Healthcare | 0.9% | $9.9m | 141,914 | -24% | reduced |
| 46 | VERA VERA THERAPEUTICS INC | Healthcare | 0.8% | $9.6m | 224,289 | 28% | added |
| 47 | ROIV ROIVANT SCIENCES LTD | Healthcare | 0.8% | $9.5m | 268,008 | 29% | added |
| 48 | CGON CG ONCOLOGY INC | Healthcare | 0.8% | $9.1m | 128,286 | -23% | reduced |
| 49 | AMRX AMNEAL PHARMACEUTICALS INC | Healthcare | 0.7% | $8.3m | 480,715 | -48% | reduced |
| 50 | EPRX EUPRAXIA PHARMACEUTICALS INC | 0.7% | $8.0m | 1,210,661 | 124% | added |
What did Pfm Health Sciences, LP sell? Positions exited since the previous filing
| Stock | Prior weight | Prior value |
|---|---|---|
| ASND ASCENDIS PHARMA A/S | 20.8% | $34.8m |
| GKOS GLAUKOS CORP | 13.9% | $23.2m |
| CNTA CENTESSA PHARMACEUTICALS PLC | 12.6% | $21.0m |
| ASND ASCENDIS PHARMA A/S | 10.1% | $16.9m |
| NEO NEOGENOMICS INC | 7.9% | $13.2m |
| DXCM DEXCOM INC | 5.6% | $9.4m |
| 430 TERNS PHARMACEUTICALS INC | 5.5% | $9.1m |
| SLNOEUR SOLENO THERAPEUTICS INC | 5.0% | $8.3m |
| BLLN BILLIONTOONE INC | 4.2% | $7.0m |
| CAH CARDINAL HEALTH INC | 4.0% | $6.7m |
| ALHC ALIGNMENT HEALTHCARE INC | 3.8% | $6.3m |
| PSNL PERSONALIS INC | 3.3% | $5.5m |
| MDLN MEDLINE INC | 2.3% | $3.9m |
| GMED GLOBUS MED INC | 0.9% | $1.5m |
Sector mix
| Sector | Weight |
|---|---|
| Healthcare | 98.2% |
Sectors cover positions whose ticker resolved to a sector; the remainder is unclassified, not cash.
Filing history
How concentrated is Pfm Health Sciences, LP's portfolio?
Across every quarter Pfm Health Sciences, LP has filed, its median largest position is 6.7% of the book and its median top-ten weight is 38.6%, which WhaleCreep classifies as concentrated (the gate is a median largest position of 5%). Of 12.0 completed holding spells, the median lasted 1.0 quarters; 96.0 positions are still open and their final length is unknown.